Mary Lisbeth D’Amico

OrthoMimetics, the first technology spin-out from the Cambridge-MIT Institute, Cambridge, UK, has begun its search for initial funding.

A new proposal from the European Investment Fund seeks to accelerate the success of European technology transfer projects. A noble idea, says Mary Lisbeth D'Amico in her fortnightly column, but no one has yet stepped up to foot the bill.

For her latest fortnightly funding column, Mary Lisbeth D'Amico set out to find European seed funders. That was as easy as finding a needle in a haystack.

Reports of incubators' demise were premature

Mary Lisbeth D'Amico's fortnightly funding column looks at the contenders for Europe’s premier exchange for growth stocks.

One of Europe’s biggest research organisations, Fraunhofer Gesellschaft in Germany, is pushing to close its first venture fund to finance spin-off companies from the institute.

Mary Lisbeth D'Amico's first fortnightly funding column reveals how coming out on top in a start-up talent show does not guarantee funding.

Oslo-based anticancer company Algeta has closed a series A financing round totaling €23 million.